Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Jin, Z., Zhao, Y., Sun, Y., Zhang, B., Wang, H., Wu, Y., Zhu, Y., Zhu, C., Hu, T., Du, X., Duan, Y., Yu, J., Yang, X., Yang, X., Yang, K., Liu, X., Guddat, L.W., Xiao, G., Zhang, L., Yang, H., Rao, Z.(2020) Nat Struct Mol Biol 27: 529-532
- PubMed: 32382072 
- DOI: https://doi.org/10.1038/s41594-020-0440-6
- Primary Citation of Related Structures:  
7BUY - PubMed Abstract: 
The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (M pro ). Here, the X-ray crystal structure of M pro in complex with carmofur reveals that the carbonyl reactive group of carmofur is covalently bound to catalytic Cys145, whereas its fatty acid tail occupies the hydrophobic S2 subsite ...